1 July 2023 false No description of principal activity Taxfiler 2024.5 11801853business:PrivateLimitedCompanyLtd2023-07-012024-06-30 118018532023-06-30 118018532023-07-012024-06-30 11801853business:AuditExemptWithAccountantsReport2023-07-012024-06-30 11801853business:FilletedAccounts2023-07-012024-06-30 118018532024-06-30 11801853business:Director12023-07-012024-06-30 11801853business:RegisteredOffice2023-07-012024-06-30 118018532023-06-30 11801853core:WithinOneYear2024-06-30 11801853core:WithinOneYear2023-06-30 11801853core:ShareCapitalcore:PreviouslyStatedAmount2024-06-30 11801853core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 11801853core:SharePremiumcore:PreviouslyStatedAmount2024-06-30 11801853core:SharePremiumcore:PreviouslyStatedAmount2023-06-30 11801853core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-06-30 11801853core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 11801853core:PreviouslyStatedAmount2024-06-30 11801853core:PreviouslyStatedAmount2023-06-30 11801853business:SmallEntities2023-07-012024-06-30 11801853countries:EnglandWales2023-07-012024-06-30 118018532022-07-012023-06-30 iso4217:GBP xbrli:pure
Company Registration No. 11801853 (England and Wales)
Drewery Medical Limited Unaudited accounts for the year ended 30 June 2024
Drewery Medical Limited Unaudited accounts Contents
Page
- 2 -
Drewery Medical Limited Company Information for the year ended 30 June 2024
Director
Iain Drewery
Company Number
11801853 (England and Wales)
Registered Office
21 Ropery Walk Pocklington York North Yorkshire YO42 2BF England
Accountants
Monroe Accountants Ltd 21 Ropery Walk Pocklington York YO42 2BF
- 3 -
Drewery Medical Limited Statement of financial position as at 30 June 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Investments
121,924 
121,924 
Current assets
Cash at bank and in hand
3,191 
4,470 
Creditors: amounts falling due within one year
(10,668)
(12,220)
Net current liabilities
(7,477)
(7,750)
Net assets
114,447 
114,174 
Capital and reserves
Called up share capital
100 
100 
Share premium
81,825 
81,825 
Profit and loss account
32,522 
32,249 
Shareholders' funds
114,447 
114,174 
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 October 2024 and were signed on its behalf by
Iain Drewery Director Company Registration No. 11801853
- 4 -
Drewery Medical Limited Notes to the Accounts for the year ended 30 June 2024
1
Statutory information
Drewery Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 11801853. The registered office is 21 Ropery Walk, Pocklington, York, North Yorkshire, YO42 2BF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
3
Accounting policies
Judgements & Key sources of estimation uncertainty
In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling. Monetary amounts in these financial statements are rounded to the nearest £.
Fixed Asset Investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss. A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities. An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate. Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
Cash & Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
- 5 -
Drewery Medical Limited Notes to the Accounts for the year ended 30 June 2024
Financial Instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method
4
Investments
Other investments 
£ 
Valuation at 1 July 2023
121,924 
Valuation at 30 June 2024
121,924 
5
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Loans from directors
10,368 
11,180 
Accruals
300 
1,040 
10,668 
12,220 
6
Transactions with related parties
Included within other creditors, at the balance sheet date, is an amount of £10,368 (2023 - £11,180) owed to the director. This balance includes interest charged at 2.5% and the loan is repayable on demand.
7
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -